WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Judith

Question: I’m worried and need some advice. My hair is thinning with especially noticeable hair loss near my temples. Is there anything I can do to make my hair thicker?

Answer: Hi, Judith. There are various potential reasons for thinning hair in women so we would advise you to have an individual consultation – either in person or online – in order to obtain a confirmed diagnosis.

Obviously the appropriate hair loss treatment will be decided once the cause has been established.

The following information regarding causes of hair loss which have symptoms the most consistent with those you describe may be helpful in the meantime, however.

Types of Womens Hair Loss - Areas of Scalp Affected by Temporary and Permanent HairLoss Conditions

Female Pattern Hair Loss – this is the diagnosis that most accurately fits the details you have given regarding your shedding. It is an extremely common permanent, genetic women’s hair loss condition – not to mention one that can be effectively managed with clinically-proven treatments.

This causes thinning hair at the top of the scalp, from hairline and temples to crown, and a general drop in hair density. Symptoms women notice first tend to include decreased volume, thinning at the temples and their parting becoming wider.

A topical hair loss solution known as high strength minoxidil is both MHRA-licensed and FDA-approved for the treatment of Female Pattern Hair Loss. This stimulates localised hair growth and can be used in conjunction with various hair growth supporting products.

These include the FDA-cleared LaserBands which use targeted low-level laser therapy to promote regrowth and stronger hair at home, and Hair Vitalics for Women – specially-formulated food supplements containing key vitamins, minerals, amino acids and botanical extracts such as biotin, zinc and selenium to promote the maintenance of normal healthy hair growth.

Telogen Effluvium – this is a temporary condition which causes intensely thinning hair from all over the scalp. The hair fall generally becomes noticeable around three months after being triggered and can affect up to 30 per cent of a person’s scalp hair at once.

Some issues that can spark this problem include nutritional deficiencies, emotional or physical stress, an underlying medical condition or side effects from prescription medication.

This temporary hair loss can last up to six months, with hair growth returning to normal naturally once the underlying issue has been addressed though, Telogen Effluvium treatment is also available to help speed this process along.

Telogen Effluvium may trigger the premature onset of Female Pattern Hair Loss in those with the relevant genetic predisposition, or exacerbate the condition if it is already present, as both issues can occur simultaneously. Where this is the case, both conditions can also be treated at once.

There are a range of temporary, cosmetic hair loss concealer products, such as microscopic fibres and coloured hair sprays that are used to make hair look thicker by colouring in the scalp so it is less obvious.

These are applied at least once daily and may be used to fake fuller hair in the meantime but they will not stop hair loss or treat thinning hair so the underlying problem will not be addressed, which is problematic in the case of Female Pattern Baldness as this condition gets gradually worse over time.

As before, the first step to treating hair loss is to identify the cause so we recommend having a consultation as your next move.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

This client has two separate conditions – Chronic Telogen Effluvium and Female Pattern Hair Loss which are being treated simultaneously, thanks to a personalised treatment plan available from Belgravia.

Find out what this client had to say and see her regrowth results close up, or find out more about treating Chronic Telogen Effluvium and Female Pattern Hair Loss by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Female Hair Loss Treatment

Chronic Telogen Effluvium Treatment


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Miriam

Question: I’m about to start being treated with herceptin – does this cause hair loss?

Answer: Hi, Miriam. As you probably know, Herceptin is the brand name for chemotherapy drug, trastuzumab.

It is commonly used by the NHS for the treatment of certain forms of breast cancer, oesophageal cancer and stomach cancer.

Cancer charity ribbon

There are no reported adverse events relating to hair loss of any kind associated with Herceptin / trastuzumab; you will be able to see the relevant potential side effects on the patient information leaflet for this medication which you can ask your oncologist for if they do not already provide you with a copy.

Herceptin is often used in conjunction with other drugs, therefore, you will need to explore the relevant patient information leaflets for these too – or ask your oncologist – to establish any potential Anagen Effluvium hair loss risks, including interactions with any other medications you may already be taking.

If hair loss during chemotherapy becomes a concern, you could investigate the possibility of cold cap therapy administered via a helmet-like scalp cooling system worn during chemo. This chills the scalp to such low temperatures that the chemo drugs are deterred from reaching, and destroying, the follicles, thereby preventing hair loss.

As having cancer is obviously incredibly distressing emotionally, and can also take its toll physically, there is the chance of stress-related hair loss happening.

This is a temporary condition called Telogen Effluvium where it lasts up to six months, and Chronic Telogen Effluvium – or Diffuse Thinning – when it lasts for at least six months.

It causes hair fall from all over the scalp, leaving thinning hair that first presents up to three months after having been triggered but usually grows back naturally.

The shedding can be intense but this is normal; up to 30 per cent of scalp hair – sometimes more – can be affected at the same time, which can be worrying to see when it falls out. However, normal hair growth should resume in due course.

For those who are not undergoing chemo Telogen Effluvium treatment may be a consideration, however, for anyone who has completed their chemotherapy course, a letter from their oncologist confirming they are suitable for hair loss treatment would be required by any Belgravia patients.

If you have any concerns regarding hairloss from your cancer treatment we advise you to speak to your doctor and/or oncologist about this as they will be able to give you a more personalised response based on your medical profile.

We wish you the very best of luck with your chemo and if you have any further general queries, please do let us know.


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Aclaris Therapeutics has announced the six-month findings from its Phase 2 open-label clinical trial into ATI-502 – a topical hair loss solution being tested as a potential treatment for Male Pattern Baldness and Female Pattern Hair Loss.

The physician-led biopharma released its latest update on this investigational JAK inhibitor drug in a press release dated 17th June 2019. It noted that this data is from the trial’s mid-point, with 12-month findings due in the next six months, by the end of 2019.

ATI-502 is one of the company’s leading hopes and is currently being fast-tracked by the FDA for use as a potential treatment for autoimmune hair loss caused by Alopecia Areata, Alopecia Totalis and Alopecia Universalis.

Women’s hair loss improved the most

This six month update advised the trial has so far been evaluating men and women aged between 18 and 50 years old, with genetic hair loss.

Hair Loss Research Study

Each of the 23 participants who completed the full six months applied topical ATI-502 to their scalp twice per day for 26 weeks. The precise dosages were not revealed.

Of these 23 test subjects, 20 (14 of whom were male, 6 of whom were female) had “evaluable hair counts”, and 22 of them (15 male, 7 female) recorded investigator global assessment (IGA) and subject self-assessment (SSA) scores.

The mid-point data showed an overall hair count increase of 8.6 hairs/cm2 (non-vellus) at the six month mark. Whilst the male participants showed an overall increase of 5.6 hairs/cm2, the women saw almost three times that, with an overall increase recorded as 15.3 hairs/cm2.

Results from the IGA and SSA components involved subjects with positive hair growth increases being allocated a score of +1 for a slight increase, +2 for a moderate increase, or +3 for greatly increased hair growth.

Aclaris say investigators rated 73% of the participants (16/22) as “experiencing increased hair growth”, however, 82% (18/22) of the test subjects self-assessed themselves as such.

ATI-502 was found to be well-tolerated in this small-scale study as no treatment-related serious adverse events were recorded. One unrelated incidence of breast cancer was reported in week one and the affected patient withdrew immediately.

Subsequent trial may be female-focussed

According to Dr. Neal Walker, President and Chief Executive Officer of Aclaris, “This finding demonstrates that inhibiting a non-hormonal and inflammatory-mediated pathway may be an option for the treatment of AGA [Androgenetic Alopecia – male and female pattern hairloss].”

Further to this, Aclaris also advised that through recent formulation work, it “can achieve significantly higher topical concentrations of ATI-502”.

As such, Aclaris have advised that its next steps will involve initiating a double-blind, randomized, controlled Phase 2 dose-ranging clinical trial with higher concentrations of ATI-502.

It was also indicated that this trial, due to start in the first half of 2020, may potentially have a “female focus”.

Should ATI-502 make it through the relevant stages of development and be able to finally demonstrate sufficient safety, efficacy and tolerability that it is awarded the relevant licences and approvals from medical regulatory boards, such as the MHRA and FDA in the UK and USA, it will be the first significant breakthrough in this area in decades.

Currently the only MHRA-licensed and FDA-approved hair loss treatments for men and women are high strength minoxidil – a unisex topical hair loss solution – and finasteride 1mg – a one-a-day oral DHT-blocker for use by medically-suitable men only.

These clinically-proven treatments are already widely-used either on their own or in combination with hair growth supporting products such as low level laser therapy devices and highly-targeted food supplements such as Hair Vitalics, by both women looking to regrow their thinning hair and men hoping to prevent baldness.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see her regrowth results close up, or find out more about treating hereditary hair loss in women by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see her regrowth results close up, or find out more about treating hereditary hair loss in women by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Troy

Question: I’ve been using Regaine for years but just the bottle I’m currently using is a year out of date. These things seem to last for ages so that’s not that long right? Does that mean it’s still ok to use? I noticed more hair loss in the past couple of months so could that be the reason? It normally works well for me. I’m 23 btw with general MPB, no fin. Thanks.

Answer: Hi, Troy. No medication should be used if it is past its use-by or expiry date; this includes Regaine and any other hair loss treatment.

With specific regard to high strength minoxidil, the main reasons for not using this treatment when it is ‘out of date’ are:

  • a higher risk of side effects (such as skin irritation)
  • a lower chance of the drug being effective (after the expiry date the solution is likely to become increasingly weaker over time, so it may not work as well)
  • an increased risk of hair fall resuming (if the solution is weaker than it should be, its effects may be less effective – or even completely ineffective – and the likelihood of hair loss resuming increases)
hair loss treatment medication expiry date

Specialist hair loss clinics, including the dedicated pharmacies here at Belgravia, tend to only dispense medications to patients in three-to-six month batches at a time so the drugs and appropriate expiry dates align and their treatment is always ‘in date’. When men, or women, choose to purchase ‘over the counter’ hair loss products such as Regaine, there is no such supervision.

This is why it is important to be cautious and always check the expiry or use-by dates when these solutions are on special offer, especially on bulk deals such as ‘3 for 2’.

Some people may see these offers as a good chance to stock up, however, this may not be the case. For example, if the expiry date is two months away, there is no point in buying three months worth – or more – as by the third month these additional supplies would be out of date before it was even time to open them.

Furthermore, you should only ever use the medication in the specified dosage, either once or twice per day as detailed on the accompanying patient information leaflet.

Therefore, the additional product should be disposed of as it cannot be used either more frequently nor can you use larger amounts than specified (this will not make the minoxidil work any better or faster and may lead to increase risk of adverse events) in order to use it up before it expires.

It may be the case that this is why your Regaine is so far out of date, or you may have simply found an old product you had forgotten about; alternatively, if you purchased this recently and it is already out of date, you should make the retailer aware so they can issue you with a refund or replace it with a suitably-dated product.

If you did not buy the Male Pattern Hair Loss product from a reputable vendor we recommend you are sure to do this in future; the UK’s MHRA body has increased its campaigns promoting awareness of the dangers of buying medication – including hair loss treatments – online or from unusual stockists.

There is a big problem with fake medication being sold online – often not actually being what it claims to be on the labels, as well as real medication which has either expired, is faulty or has spoiled due to incorrect storage.

Belgravia Centre before and after regrow thinning crown hair loss treatment success story
Click to View Belgravia Centre Male Pattern Hair Loss Treatment Success Stories (Results May Vary and Are Not Guaranteed)

It is likely the increased shedding and thinning hair you are seeing is the result of your treatment being ineffective, especially if you have not had any problems with it until now. We recommend restarting your treatment as quickly as possible with a replacement solution in order to get your hair back on track, though it may take three months for everything to properly right itself, due to the natural timing of the hair growth cycle.

One other issue worth considering is whether your additional hair fall is coming from the top of your scalp or from the whole head. If you are losing hair from all over, it is likely to be due to a separate, additional hair loss condition.

Telogen Effluvium is a temporary issue which disrupts normal hair growth. It generally takes around three months for the diffuse shedding to present so – as it is now June – think back to any particularly stressful life events or health problems that may have started, or peaked, around March time.

As Telogen Effluvium can be active simultaneously alongside Male Pattern Baldness, it can make your genetic hair loss appear worse; it should correct itself within approximately six months as long as the underlying trigger has been dealt with. There are also Telogen Effluvium treatment options, that can be combined with an appropriate Male Pattern Hair Loss treatment course by trained specialists, if desired.

Hopefully you will find your hair growth is back to normal within the next three to six months but, if you would like a professional hair loss consultation before then to determine the exact issue at play, this can be arranged via our website, whether for an in-person assessment at one of our Central London hair clinics, or for a remote Online Consultation.


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see her regrowth results close up, or find out more about treating hereditary hair loss in women by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

A short paper published in the Dermatologic Therapy journal on 6th June 2019 outlines the outcome from using Biofibre® artificial hair implants on men and women with hair loss.

This method, which has been in development for over ten years, implants synthetic hairs during a hair transplant operation, and, the company stresses, must be carried out by a specifically trained professional, not least because it involves using new, proprietary MediCap equipment.

The key conditions this was used to address were Male Pattern Baldness, Female Pattern Hair Loss and scarring alopecia, also known as Cicatricial Alopecia.

Hair transplant surgery

During normal hair transplant operations, donor hair is required. This is the term for follicles harvested from areas of the patient’s scalp which are unaffected by their specific hair loss condition. These follicles are then implanted into incisions in the sparser areas they want to fill out.

For example, in the case of Female or Male Pattern Baldness, which affects the follicles along the top of the head, from hairline and temples to crown, only, ‘donor hair’ is taken from the sides and/or back of the head.

Where there is not enough good quality donor hair available, hair restoration surgery may not be possible; this tends to be the case where the patient has extensive follicular damage, either through advanced baldness, where the scalp has taken on a smooth, shiny appearance, or due to scarring.

This is one of the reasons why hair transplants for Cicatricial Alopecia patients, who have often lost their hair to scarring caused by burns or injury, are decided on a case-by-case basis by specialist surgeons, rather than there being a general rule about it being a suitable procedure for those with this condition.

Biofibre® hair implantation system

Biofibre® hair implantation system negates the need for donor hair as it uses artificial hair, which the peer-reviewed, published report describes as having “special physical, chemical and mechanical features”.

According to Biofibre marketing literature, the out-patient procedure requires no down-time and can be done at a rate of 800 hairs implanted per hour, in order to provide a ‘high hair density’ result. The average number per procedure is 2,500 synthetic strands. Continues below…

They offer 14 different hair colours, and strands of different lengths that mimic all hair types and textures, plus further claim that it is a painless and reversible op. Also, as the hair is not real, it will not age or go grey.

There are, however, a number of downsides to this promising-sounding surgery. Additional ‘touch-up’ surgeries may be needed in order to maintain the initial look, and patients will need to follow scalp- and hair-aftercare both to properly preserve their results and for hygiene reasons.

The artificial hairs are believed to last around 7 to 8 years, and shed at a rate of approximately 10 per cent per year.

The Biofibre® hair implantation system is not suitable for everyone; the company website states that patients who are sensitive to “the pre-implant test or suffering from scalp diseases or overall illness, such as diabetes, lupus, HIV, hepatitis, autoimmune diseases, etc.” will find the system “cannot be be used in all scalp area with same degree of performance”.

Potential hair loss solution for some candidates

If a hair transplant candidate no longer needs to have sufficient – or, indeed, any – donor hair, it widens the scope of those who may be suitable for this type of surgery.

Biofibre Hair Implants System hair transplant synthetic hair

There are already clinically-proven, MHRA-licensed and FDA-approved hair loss treatments available for Male and Female Pattern Baldness, which can be used so long as the follicles are still functioning – even if they only produce thinning hair – and the individuals are deemed medically-suitable.

In cases of true baldness – which is rarely seen in women with genetic hairloss, but common in men – and Cicatricial Alopecia, there are currently no widely accepted remedies, other than cosmetic solutions, such as wigs.

Therefore, should this innovation prove viable, this may provide men and women who may currently have no real options for getting their hair back, with a way to have a full head of hair again. This is, of course, as long as the procedure and materials are proven to be both safe and effective for long-term use.

Furthermore, whereas with a regular FUE or FUT hair restoration operation it can take around 12 months to see the full results of the procedure, the results from Biofibre® hair implantation, using a novel CE 0373 certified medical device, are said to be instant – something that will no doubt appeal to clients who want on-demand, ‘quick-fix’ hair loss solutions.

An international team* studied how the synthetic hair implants performed on 1,518 patients – a mix of men and women – with varying degrees of baldness from genetic hair loss or burns and scars.

Their findings state: “According to our experience, this technique gives immediate and visible results without scarring or hospitalization and the aesthetic results are very encouraging for both male and female patients with a rapid recovery of self‐esteem and psychological well‐being.”

We look forward to seeing wider-ranging trials involving this innovative system, which does not yet have FDA-clearance but has been authorised by its Australian equivalent body, and will report on any updates here on the Belgravia blog.

*The researchers came from the Department of Dermatology at the University of Parma, the Clinic of Dermatology in Ferrara, and the Department of Dermatology at Rome’s University G. Marconi, all in Italy, the Department of Dermatology at University Cluj‐Napoca in Romania, the Department of Dermatology at Fortis Hospital, Shalimar Bagh, India, the University of Cairo’s Department of Dermatology in Egypt, and both the Department of General, Vascular and Abdominal Surgery, and the Department of Dermatology, Venereology and Dermatologic surgery, at the Medical Institute of Ministry of Interior in Sofia, Bulgaria.

Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Polycystic ovary syndrome, commonly known as PCOS, is believed to affect 1 in every 5 women in the UK, according to NHS figures.

PCOS polycystic ovary syndrome womens health hair loss

It is an endocrine disorder which affects the normal functioning of the ovaries and can cause both hirsutism (excessive hair growth issues), and hair loss.

Although this shedding can be a side effect of PCOS medication, such as Letrozole (Femara), here we explain why PCOS is often linked to the genetic condition, Female Pattern Hair Loss.

Hyperandrogenism and androgenic alopecia

Hyperandrogenism – the term given to excessive male hormone (androgen) production – is a key symptom associated with PCOS. Androgens are the group of steroid hormones, naturally present in both men and women, that regulate the development of male characteristics.

Female Pattern Hair Loss, also known as androgenetic – or androgenic – alopecia, involves the androgen dihydrotestosterone (DHT) binding to susceptible follicles, causing increasingly thinning hair to the top and frontal, temporal regions of the scalp.

Dihydrostestosterone DHT diagram

Though it can present in those with the relevant genetic predisposition any time following puberty, it is more common for women to develop this type of hair loss when they are in their 30s or 40s.

Due to the fact that stress – whether physical, such as an underlying medical issue eg. PCOS, or emotional – can induce premature hairloss in those with an existing genetic predisposition, there are numerous reports of women now starting to lose their hair in their 20’s – something widely blamed on the pressure of modern life.

For those with PCOS who do not have the relevant inherited predisposition towards Female Pattern Hair Loss, excessive androgen production may cause shedding in a similar pattern.

Female Pattern Hair Loss and hyperandrogenism review

The Journal of Clinical Endocrinology and Metabolism published a report into the associations between Female Pattern Hair Loss and Hyperandrogensim in February 2019, which has recently also appeared in the July issue.

Investigations were carried out by a ‘task force’ of experts in dermatology, endocrinology and reproductive endocrinology, which was appointed by the Androgen Excess and PCOS Society.

The team’s evaluations came from an in-depth, intelligence-gathering exercise using agreed-upon, peer-reviewed studies into Female Pattern Hair Loss, up to December 2017, to determine the most important facts that hair loss specialists and medical practitioners in the field should be aware of.

The following conclusions were drawn:

Womens-hair-loss-consultation-belgravia-centre-hairloss-treatment-regrowth

1 “The term “female pattern hair loss” should be used, avoiding previous terms of alopecia or androgenetic alopecia”; this is due to many women finding the latter wording particularly upsetting.

2 “The two typical patterns of female pattern baldness are centrifugal expansion in the mid scalp, and a frontal accentuation or Christmas tree pattern.” This essentially means that the key areas of the scalp affected by female pattern hair loss, and typical signs, include hair loss that starts as a widening of the (middle) parting and spreads outwards over time as the follicles along the vertex (top of the scalp from hairline to crown), frontal hair loss at the temples.

3 “Isolated female pattern hair loss should not be considered a sign of hyperandrogenism when androgen levels are normal.” Hair loss can be a sign of an underlying health issue, including PCOS. However, as this is an hereditary condition, where there is thinning in the same pattern as genetic hair loss but the patient’s androgen levels are normal, PCOS is unlikely to be a factor.

4 “The assessment of patients with female pattern hairloss is primarily clinical.” There is no need to carry out a biopsy in order to diagnose genetic hair loss. A trained specialist can spot this condition via a scalp assessment and medical information about the patient.

5 “In all patients [thought to potentially have PCOS] with female pattern hair loss, assessment of a possible androgen excess is mandatory. Measurement of vitamin D, iron, zinc, thyroid hormones, and prolactin are optional but recommended.” Belgravia always recommends women worried about losing their hair have a full blood count blood test where possible, specifically covering vitamin levels for vitamin D and vitamin B12, ferritin and zinc, thyroid hormones and diabetes mellitus, before visiting a hair loss specialist for a consultation, and bring their results along with them.

6 “Treatment of female pattern hair loss should start with minoxidil (5%), adding 5α-reductase inhibitors or antiandrogens when there is severe hair loss or hyperandrogenism”. Currently, high strength minoxidil is the only women’s hair loss treatment that is both MHRA-licensed and FDA-approved for this purpose.

Anyone concerned about thinning hair, with or without an additional diagnosis of PCOS, may find a consultation at a dedicated hair loss clinic helpful. That way, a professional hair specialist can provide a confirmed diagnosis and personalised recommendations for appropriate hair loss solutions based upon their findings and the individual’s medical profile.


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories